Tenon Medical, Inc. filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware on August 6, 2026, effecting a 1-for-35 reverse stock split of its common stock. The transaction became effective at 12:01 a.m. Eastern Time on August 10, 2026, following shareholder approval at the July 23, 2026 annual meeting. Every thirty-five shares were combined into one share, with fractional entitlements rounded up to the next whole number and no cash paid for fractions. The split aims to meet Nasdaq Capital Market's minimum $1.00 average closing price requirement for continued listing. Proportionate adjustments were made to exercise prices and share counts for outstanding stock options, warrants, and restricted stock units. Tenon Medical is a medical device company dedicated to transforming care for patients with sacro-pelvic disorders.
